ScanSource Form 144: Minor Insider Sale Scheduled for 20 Jun 2025

Rhea-AI Filing Summary

ScanSource, Inc. (SCSC) – Form 144 filing overview

This Form 144 is a notice of a proposed insider sale of 6,738 common shares of ScanSource, Inc., to be executed through Merrill Lynch, Atlanta. The shares have an aggregate market value of $278,077.26, or roughly 0.03 % of the company’s 22.6 million shares outstanding. The transaction is scheduled for 20 June 2025 on the NASDAQ.

The seller acquired the shares through multiple equity-compensation events, including restricted stock unit (RSU) and performance stock unit (PSU) vestings dated between August 2023 and June 2025. No other sales have been reported by this person in the past three months, and no information is provided that would indicate a Rule 10b5-1 trading plan.

The filing is strictly a notice; it does not confirm that the sale has occurred, nor does it disclose the insider’s name, position, or additional context. Given the modest size of the trade relative to shares outstanding and the absence of additional insider activity, the market impact is expected to be limited, though investors may monitor further filings for trend confirmation.

Insights

Equity Research Analyst

TL;DR: Planned insider sale is small relative to float; neutral impact.

The Form 144 discloses a forthcoming disposition of 6,738 SCSC shares worth ~$278k, less than one-thirtieth of one percent of outstanding shares. The stock units stem from routine equity compensation vestings, suggesting liquidity rather than a strategic exit. With no clustered selling and no performance commentary, the filing is informational but not financially material. I view the event as neutral for valuation models and would not adjust forecasts or risk premia based solely on this notice.

Corporate Governance Specialist

TL;DR: Standard insider liquidity event; governance signal minimal.

The absence of a 10b5-1 plan date and the modest transaction size point to a discretionary sale but do not violate any governance norms. Transparency via Form 144 filing is appropriate. Because total value is immaterial and no pattern of sequential sales is evident, I classify governance risk as low. Continued monitoring of subsequent Forms 4 will confirm whether this is an isolated event or part of a broader disposition strategy.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 3455 PEACHTREE RD NE SUITE 1000 ATLANTA GA 30326	6738	278077.26	22595608	06/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	06/07/2025	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1364	06/07/2025	COMPENSATORY PAYMENT
COMMON	06/07/2024	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1369	06/07/2024	COMPENSATORY PAYMENT
COMMON	08/27/2024	PERFORMANCE STOCK UNIT VEST	SCANSOURCE, INC			2092	08/27/2024	COMPENSATORY PAYMENT
COMMON	08/26/2023	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1080	08/26/2023	COMPENSATORY PAYMENT
COMMON	08/27/2023	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			833	08/27/2023	COMPENSATORY PAYMENT

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ScanSource (SCSC) shares are being registered for sale in this Form 144?

The filing covers 6,738 common shares of ScanSource, Inc.

What is the aggregate market value of the shares listed in the Form 144?

The shares are valued at approximately $278,077.26 based on the market price at the time of filing.

When is the proposed sale date for the SCSC shares?

The approximate sale date disclosed is June 20, 2025.

Through which broker will the SCSC insider execute the trade?

The broker named is Merrill Lynch, 3455 Peachtree Rd NE, Suite 1000, Atlanta, GA 30326.

What percentage of ScanSource’s outstanding shares does the proposed sale represent?

The 6,738 shares equal roughly 0.03 % of the 22,595,608 shares outstanding.